[1] Patel KN ,Shaha AR. Poorly differentiated and anaplastic thyroid cancer[J].Cancer Control,2006,28(16):119-128. [2] Okugawa Y, Tanaka K, Inoue Y,et al. Brain-derived neurotrophic factor/tropomyosin-related kinase B pathwayin gastric cancer[J].Br J Cancer,2013,108(1):121-130. [3] Sinkevicius KW, Kriegel C,Bellaria KJ, et al.Neurotrophin receptor TrkB promotes lung adenocarcinoma metastasis[J].Proc Natl Acad Sci USA,2014,111(28):10299-10304. [4] Fujikawa H ,Tanakak ,Toiyama Y,et al. High TrkB expression levels are associated with poor prognosis and EMT induction in colorectal cancer cells[J].J Gastroenterol, 2012,47(7):775-784. [5] Russell JP ,Powell DJ, Cunnane M,et al. THE TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium[J].Oncogene,2000,19(50):5729-5735. [6] 李树玲,新编头颈肿瘤学[M].北京:科学技术文献出版社,2002:86-88. [7] Sobin L.TNM Classification of Malignant Tummors[Z].2009 7th edn.John Wiley Sons,New York. [8] Shimizu M,Saliton Y,Itoh H.Immunohistochemical staining of H-ras oncogene product in normal, genign and malignant human pancreatic tissues[J].Hum Pathol,1990, 607-661. [9] Douma S, Van LT, Zevenhoven J ,et al. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB[J].Nature,2004,430(7003):1034-1039. [10] Desmet DJ.The neurotrophic receptor TrkB: a drug target in anti-cancer therapy[J].Cell Mol Life Sci,2006,63(7):755-759. [11] Lee J, Jiffar T, Kupferman ME .A Novel Role for BDNF-TrkB in the regulation of chemotherapy resistance in head and neck squamous cell carcinoma[J].PLoS One,2012,7(1):30246. [13] Moon A ,Won KY,Lee JY.et al.Expression of BDNF, TrkB, and p53 in early-stage squamous cell carcinoma of the uterine cervix[J].Pathology,2011,43(5):453-458. [14] Lisa M.Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression[J].Proc Natl Acad Sci USA,1999,96(8):4540-4545.
2019, Vol. 36 
